Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Share Price

Price 0.145p on 21-10-2026 at 17:05:12
Change -0.015p -9.38%
Buy 0.15p
Sell 0.14p
Last Trade: Unknown 5,000,000.00 at 0.15p
Day's Volume: 318,841,996
Last Close: 0.145p
Open: 0.175p
ISIN: GB00BLH13C52
Day's Range 0.145p - 0.195p
52wk Range: 0.125p - 0.525p
Market Capitalisation: £1.91m
VWAP: 0.181166p
Shares in Issue: 1.32b

ValiRx (VAL) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 5,000,000 0.15p Ordinary
16:32:04 - 21-Oct-26
Unknown* 5,000,000 0.18p Ordinary
16:31:13 - 21-Oct-26
Sell* 4,000,000 0.14p Ordinary
16:21:14 - 21-Oct-26
Buy* 500,000 0.1467p Ordinary
16:11:22 - 21-Oct-26
Sell* 31,000 0.1405p Ordinary
16:08:30 - 21-Oct-26
Buy* 675,951 0.1472p Ordinary
15:52:20 - 21-Oct-26
Buy* 230,000 0.1475p Ordinary
15:49:12 - 21-Oct-26
Buy* 1,000,000 0.148p Ordinary
15:47:55 - 21-Oct-26
Sell* 7,961 0.14p SI Trade
15:37:58 - 21-Oct-26
Sell* 174,215 0.1405p Ordinary
15:23:30 - 21-Oct-26
See more ValiRx trades

ValiRx (VAL) Share Price History

Time period:
to
Date Open High Low Close Volume
20th Oct 2026 (Tue) 0.13 0.175 0.13 0.16 151,517,709
19th Oct 2026 (Mon) 0.13 0.13 0.13 0.13 3,869,934
16th Oct 2026 (Fri) 0.13 0.13 0.13 0.13 1,475,119
15th Oct 2026 (Thu) 0.13 0.13 0.13 0.13 732,182
14th Oct 2026 (Wed) 0.13 0.13 0.13 0.13 47,551
13th Oct 2026 (Tue) 0.135 0.135 0.13 0.13 949,496
12th Oct 2026 (Mon) 0.135 0.135 0.135 0.135 3,739,547
9th Oct 2026 (Fri) 0.135 0.135 0.135 0.135 3,778,754
8th Oct 2026 (Thu) 0.135 0.135 0.135 0.135 179,963
7th Oct 2026 (Wed) 0.135 0.135 0.135 0.135 1,664,378
6th Oct 2026 (Tue) 0.135 0.135 0.135 0.135 34,698
5th Oct 2026 (Mon) 0.135 0.135 0.135 0.135 3,004,457
2nd Oct 2026 (Fri) 0.135 0.135 0.135 0.135 969,096
1st Oct 2026 (Thu) 0.135 0.135 0.135 0.135 900,905
30th Sep 2026 (Wed) 0.125 0.135 0.125 0.135 6,149,045
29th Sep 2026 (Tue) 0.125 0.125 0.125 0.125 776,850
28th Sep 2026 (Mon) 0.125 0.125 0.125 0.125 4,208,795
25th Sep 2026 (Fri) 0.125 0.125 0.125 0.125 1,141,053
24th Sep 2026 (Thu) 0.13 0.13 0.125 0.125 20,128,568
23rd Sep 2026 (Wed) 0.135 0.135 0.13 0.13 4,096,960
22nd Sep 2026 (Tue) 0.135 0.135 0.135 0.135 1,002,958
21st Sep 2026 (Mon) 0.14 0.14 0.135 0.135 5,326,975
See more ValiRx price history

ValiRx (VAL) Regulatory News

Date Source Headline
15th Sep 2026 7:00 am RNS Half-year Financial Report
10th Aug 2026 7:00 am RNS Cytolytix Patent Update
17th Jul 2026 12:25 pm RNS Result of AGM, Warrants & Directorate Change
22nd Jun 2026 7:00 am RNS Conclusion of Evaluation with University of Dundee
22nd Jun 2026 7:00 am RNS Final Results & Notice of AGM
2nd Jun 2026 7:00 am RNS Conclusion of Evaluation with Stingray
1st Jun 2026 7:00 am RNS ValiRx Exercises Option on Evaluation Asset
27th May 2026 7:00 am RNS Cytolytix Patent Granted
21st May 2026 7:00 am RNS Result of Oversubscribed WRAP Retail Offer
18th May 2026 7:00 am RNS WRAP Retail Offer for up to £150,000
See more ValiRx regulatory news

ValiRx (VAL) Share News

WINNERS & LOSERS: Mobico and Ashtead surge on takeover news

21st Oct 2026 10:58

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

ValiRx subsidiary Cytolytix nears "significant" European patent win

10th Aug 2026 11:10

(Alliance News) - ValiRx PLC on Monday announced that the European Patent Office intends to grant a patent for "a key part" of majority-owned subsidiary Cytolytix Ltd's intellectual property portfolio. Read More

UK shareholder meetings calendar - next 7 days

10th Jul 2026 13:43

Read More

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

22nd Jun 2026 14:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

27th May 2026 20:36

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptides and Uses Thereof" granted. Notes the patent forms a "key part" of Cytolytix's intellectual property portfolio. Says the grant of the patent boosts Cytolytix's IP position, and affirms investment in the platform developed over the last few years. Adds that it also strengthens the firm's ability to attract external investment and expands licensing and partnership opportunities. Read More

See more ValiRx news
FTSE 100 Latest
Value10,752.88
Change19.88

Login to your account

Forgot Password?

Not Registered